Recombinant AAV as a platform for translating the therapeutic potential of RNA interference

Molecular Therapy : the Journal of the American Society of Gene Therapy
Florie BorelChristian Mueller

Abstract

RNA interference has become a ubiquitous biological tool, and is being harnessed for therapeutic purposes as well. Therapeutic posttranscriptional gene silencing takes advantage of the endogenous RNAi pathway through delivery of either chemically synthesized siRNAs, or transgenes expressing hairpin-based inhibitory RNAs (e.g., shRNAs and artificial miRNAs). RNAi has expanded the field of viral gene therapy from gene replacement to gene knockdown. Here, we review various noncoding RNAs such as shRNAs, miRNAs, and miRNA decoys which can be utilized for therapeutic applications when expressed from recombinant adeno-associated vectors (AAV), and present examples of their basic design. In addition the basis of exploiting cellular miRNA profiles for detargeting AAV expression from specific cells is described. Finally, an overview of AAV-mediated RNAi preclinical studies is presented, and current RNAi-based clinical trials are reviewed.

References

Jul 5, 2002·Nature·Anton P McCaffreyMark A Kay
Mar 22, 2005·Nature Biotechnology·Adam D JudgeIan MacLachlan
Apr 5, 2005·Nature Genetics·Azra KrekNikolaus Rajewsky
Feb 7, 2006·Cell Metabolism·Christine EsauBrett P Monia
Nov 14, 2006·Nature Structural & Molecular Biology·Glen M BorchertBeverly L Davidson
Aug 19, 2007·Nature Methods·Margaret S EbertPhillip A Sharp
Oct 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Harpreet Kaur SainiAnton James Enright
Apr 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jodi L McBrideBeverly L Davidson
Jul 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sven DiederichsDaniel A Haber
Jul 31, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jeffery C GieringMark A Kay
Aug 12, 2008·Biochemical and Biophysical Research Communications·Cliff Ji-Fan LinJen-Leih Wu
Nov 13, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ryan L BoudreauBeverly L Davidson
Mar 20, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wei-Chih TsaiAnn-Ping Tsou
Jul 9, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ayse UlusoyDeniz Kirik
Aug 14, 2009·The New England Journal of Medicine·Artur V CideciyanSamuel G Jacobson
Jun 3, 2010·Genes & Development·Martin A Newman, Scott M Hammond
Aug 11, 2010·The Journal of Clinical Investigation·Dirk GrimmMark A Kay
Dec 15, 2010·Nucleic Acids Research·Chase L BeiselChristina D Smolke
Dec 24, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jun XieGuangping Gao
May 11, 2011·The Journal of Clinical Investigation·Xiaohua NiShawn E Lupold

❮ Previous
Next ❯

Citations

Sep 4, 2015·Expert Opinion on Biological Therapy·Annukka M KiveläSeppo Ylä-Herttuala
Feb 2, 2016·Nature Biotechnology·Benjamin E DevermanViviana Gradinaru
Aug 29, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Neil Aronin, Marian DiFiglia
Jul 30, 2015·Human Gene Therapy·Thomas J Corydon
Feb 19, 2016·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Saber GhadakzadehMaryam Tabrizian
Jun 20, 2015·Cellular and Molecular Life Sciences : CMLS·Carmen Berasain, Matías A Avila
Sep 16, 2015·Molecular Therapy. Nucleic Acids·Jenny K W LamSusan W S Leung
Jul 16, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Chiu-Ling ChenYu-Chen Hu
Aug 16, 2014·PloS One·Jessica Wei, Joel R Chamberlain
Jun 29, 2016·Molecular Neurobiology·Maria Sara Cipolat MisStefania Corti
Jun 9, 2016·Human Gene Therapy·Michaël HocquemillerNathalie Cartier
Aug 18, 2016·Frontiers in Molecular Neuroscience·Lorelei Stoica, Miguel Sena-Esteves
Apr 1, 2017·Nature Communications·A MalerbaG Dickson
Mar 2, 2016·International Journal of Molecular Sciences·Unnikrishnan UnniyampurathManoj N Krishnan
Jul 18, 2017·Human Gene Therapy Methods·Elena Herrera-CarrilloBen Berkhout
Oct 25, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Marta Roche-MolinaJuan A Bernal
Mar 4, 2020·Expert Opinion on Biological Therapy·Vivian Weiwen XueWilliam Chi Shing Cho
May 20, 2020·Expert Review of Neurotherapeutics·Aristide MerolaKrzysztof Bankiewicz
Jun 18, 2015·Human Molecular Genetics·Darren R BissetJoel R Chamberlain
Feb 27, 2020·Journal of Clinical Medicine·Fabian BlancJing Wang
Oct 4, 2017·Nucleic Acids Research·James M BurkeChristopher S Sullivan
Oct 10, 2018·Frontiers in Pharmacology·Bianca C BernardoJulie R McMullen
Jun 13, 2017·Nano Reviews & Experiments·Haruhisa MiyazawaYoshiyuki Morishita
Feb 7, 2015·Advanced Healthcare Materials·Kuei-Chang Li, Yu-Chen Hu
Jun 15, 2017·Nano Reviews & Experiments·Yusuke IgarashiYoshiyuki Morishita
Feb 3, 2019·Nature Reviews. Drug Discovery·Dan WangGuangping Gao
Jan 6, 2021·Stem Cell Reviews and Reports·Zafer CetinEmel Sokullu
Dec 11, 2020·Scientific Reports·Marcus DavidssonAndreas Heuer
Feb 18, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Xiangjun HeBo Feng
Feb 27, 2021·Molecular Medicine·Theodora NtetsikaIoanna Markaki
Aug 12, 2018·Journal of Molecular and Cellular Cardiology·Callum J DonaldsonLingfang Zeng
Apr 12, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Defne A Amado, Beverly L Davidson
Jul 3, 2021·International Journal of Molecular Sciences·Riccardo Di FioreJean Calleja-Agius

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Nature Reviews. Genetics
Beverly L Davidson, Paul B McCray
Frontiers in Bioscience : a Journal and Virtual Library
Sebastien Walchli, Mouldy Sioud
Methods in Enzymology
Beverly L Davidson, Scott Q Harper
Revista brasileira de reumatologia
Natália Regine de FrançaNeusa Pereira Silva
© 2021 Meta ULC. All rights reserved